Birdwatch Archive

Birdwatch Note

2024-12-06 00:40:31 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

ワクチンの有効性は変異株や、時間経過とともに低下しました(例えば厚労省の下記の研究紹介を参照)。 https://www.mhlw.go.jp/content/10900000/31_effective.pdf 製薬会社のデータだけでなく、販売後のデータでも21年前半に流行したアルファ株へのmRNAワクチンの発症予防有効性は、メタアナリシスが90.1%と報告済ですので製薬会社のデータが誤りであったかのような噂は誤解を招く投稿です。 https://link.springer.com/article/10.1186/s12916-022-02397-y/figures/1 (引用は90.1%で本本検索) https://link.springer.com/article/10.1186/s12916-022-02397-y#Fig1 日本でもアルファ変異の時の2回接種後2週間以降の有効性は95%だった事が下記の表3-(b)で紹介されています。 https://www.niid.go.jp/niid/ja/2019-ncov/2484-idsc/10614-covid19-55.html

Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1864811697590182318

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1864832257007194262
  • noteId - 1864832257007194262
  • participantId -
  • noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
  • createdAtMillis - 1733445631636
  • tweetId - 1864811697590182318
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 1
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 1
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • ワクチンの有効性は変異株や、時間経過とともに低下しました(例えば厚労省の下記の研究紹介を参照)。 https://www.mhlw.go.jp/content/10900000/31_effective.pdf 製薬会社のデータだけでなく、販売後のデータでも21年前半に流行したアルファ株へのmRNAワクチンの発症予防有効性は、メタアナリシスが90.1%と報告済ですので製薬会社のデータが誤りであったかのような噂は誤解を招く投稿です。 https://link.springer.com/article/10.1186/s12916-022-02397-y/figures/1 (引用は90.1%で本本検索) https://link.springer.com/article/10.1186/s12916-022-02397-y#Fig1 日本でもアルファ変異の時の2回接種後2週間以降の有効性は95%だった事が下記の表3-(b)で紹介されています。 https://www.niid.go.jp/niid/ja/2019-ncov/2484-idsc/10614-covid19-55.html

Note Ratings

rated at rated by
2024-12-06 06:19:21 -0600 Rating Details
2024-12-06 05:27:44 -0600 Rating Details
2024-12-06 02:44:13 -0600 Rating Details
2024-12-06 01:43:09 -0600 Rating Details
2024-12-06 01:37:31 -0600 Rating Details
2024-12-06 01:22:50 -0600 Rating Details
2024-12-06 01:14:52 -0600 Rating Details
2024-12-06 01:03:51 -0600 Rating Details
2024-12-06 00:35:42 -0600 Rating Details
2024-12-06 00:26:47 -0600 Rating Details
2024-12-05 23:45:06 -0600 Rating Details
2024-12-05 23:20:44 -0600 Rating Details
2024-12-05 23:08:13 -0600 Rating Details
2024-12-05 22:04:16 -0600 Rating Details
2024-12-05 22:02:07 -0600 Rating Details
2024-12-05 21:35:44 -0600 Rating Details
2024-12-05 21:23:39 -0600 Rating Details
2024-12-05 21:22:28 -0600 Rating Details
2024-12-05 21:19:05 -0600 Rating Details
2024-12-05 21:03:41 -0600 Rating Details
2024-12-05 20:44:19 -0600 Rating Details
2024-12-05 20:11:23 -0600 Rating Details
2024-12-05 20:07:47 -0600 Rating Details
2024-12-05 20:07:26 -0600 Rating Details
2024-12-05 20:04:17 -0600 Rating Details
2024-12-05 19:42:49 -0600 Rating Details
2024-12-05 19:24:46 -0600 Rating Details
2024-12-05 19:22:08 -0600 Rating Details
2024-12-05 19:20:22 -0600 Rating Details
2024-12-05 19:14:40 -0600 Rating Details
2024-12-05 19:13:46 -0600 Rating Details
2024-12-05 19:07:00 -0600 Rating Details
2024-12-05 19:02:17 -0600 Rating Details
2024-12-05 18:59:16 -0600 Rating Details
2024-12-05 18:55:31 -0600 Rating Details
2024-12-05 18:51:28 -0600 Rating Details
2024-12-07 14:49:11 -0600 Rating Details
2024-12-06 16:08:15 -0600 Rating Details
2024-12-06 08:00:26 -0600 Rating Details
2024-12-06 07:34:58 -0600 Rating Details
2024-12-06 02:45:27 -0600 Rating Details
2024-12-06 01:33:27 -0600 Rating Details
2024-12-05 23:35:44 -0600 Rating Details
2024-12-05 23:24:54 -0600 Rating Details
2024-12-05 22:04:52 -0600 Rating Details
2024-12-05 21:38:04 -0600 Rating Details
2024-12-05 20:59:03 -0600 Rating Details
2024-12-05 20:20:54 -0600 Rating Details
2024-12-05 20:02:29 -0600 Rating Details
2024-12-05 19:53:56 -0600 Rating Details
2024-12-05 19:42:57 -0600 Rating Details
2024-12-05 19:37:22 -0600 Rating Details
2024-12-05 19:29:34 -0600 Rating Details
2024-12-05 19:20:57 -0600 Rating Details
2024-12-05 19:11:28 -0600 Rating Details
2024-12-05 19:07:59 -0600 Rating Details
2024-12-05 18:59:02 -0600 Rating Details
2024-12-05 18:57:06 -0600 Rating Details
2024-12-05 18:56:39 -0600 Rating Details
2024-12-21 19:07:36 -0600 Rating Details
2024-12-06 23:56:30 -0600 Rating Details
2024-12-06 03:58:10 -0600 Rating Details
2024-12-06 02:13:02 -0600 Rating Details
2024-12-06 01:07:35 -0600 Rating Details
2024-12-06 00:18:49 -0600 Rating Details
2024-12-05 23:51:38 -0600 Rating Details
2024-12-05 22:54:55 -0600 Rating Details
2024-12-05 21:22:25 -0600 Rating Details
2024-12-05 20:39:52 -0600 Rating Details
2024-12-05 19:51:31 -0600 Rating Details
2024-12-05 19:32:13 -0600 Rating Details
2024-12-05 19:29:25 -0600 Rating Details
2024-12-05 19:01:12 -0600 Rating Details
2024-12-07 21:39:41 -0600 Rating Details
2024-12-06 06:10:50 -0600 Rating Details
2024-12-06 01:13:18 -0600 Rating Details
2024-12-06 01:00:29 -0600 Rating Details
2024-12-05 23:42:46 -0600 Rating Details
2024-12-05 22:53:59 -0600 Rating Details
2024-12-05 22:20:13 -0600 Rating Details
2024-12-05 22:10:54 -0600 Rating Details
2024-12-05 21:57:57 -0600 Rating Details
2024-12-05 21:30:05 -0600 Rating Details
2024-12-05 21:05:12 -0600 Rating Details
2024-12-05 21:04:26 -0600 Rating Details
2024-12-05 21:03:23 -0600 Rating Details
2024-12-05 19:30:41 -0600 Rating Details
2024-12-05 19:26:39 -0600 Rating Details
2024-12-05 19:05:35 -0600 Rating Details